Sorcin Interacts with Sarcoplasmic Reticulum Ca(2+)-ATPase and Modulates Excitation-contraction Coupling in the Heart
Overview
Authors
Affiliations
Sorcin is a 21.6-kDa Ca(2+) binding protein of the penta-EF hand family. Several studies have shown that sorcin modulates multiple proteins involved in excitation-contraction (E-C) coupling in the heart, such as the cardiac ryanodine receptor (RyR2), L-type Ca(2+) channel, and Na(+)-Ca(2+) exchanger, while it has also been shown to be phosphorylated by cAMP-dependent protein kinase (PKA). To elucidate the effects of sorcin and its PKA-dependent regulation on E-C coupling in the heart, we identified the PKA-phosphorylation site of sorcin, and found that serine178 was preferentially phosphorylated by PKA and dephosphorylated by protein phosphatase-1. Isoproterenol allowed sorcin to translocate to the sarcoplasmic reticulum (SR). In addition, adenovirus-mediated overexpression of sorcin in adult rat cardiomyocytes significantly increased both the rate of decay of the Ca(2+) transient and the SR Ca(2+) load. An assay of oxalate-facilitated Ca(2+) uptake showed that recombinant sorcin increased Ca(2+) uptake in a dose-dependent manner. These data suggest that sorcin activates the Ca(2+)-uptake function in the SR. In UM-X7. 1 cardiomyopathic hamster hearts, the relative amount of sorcin was significantly increased in the SR fraction, whereas it was significantly decreased in whole-heart homogenates. In failing hearts, PKA-phosphorylated sorcin was markedly increased, as assessed using a back-phosphorylation assay with immunoprecipitated sorcin. Our results suggest that sorcin activates Ca(2+)-ATPase-mediated Ca(2+) uptake and restores SR Ca(2+) content, and may play critical roles in compensatory mechanisms in both Ca(2+) homeostasis and cardiac dysfunction in failing hearts.
Sorcin in Cancer Development and Chemotherapeutic Drug Resistance.
Exertier C, Antonelli L, Fiorillo A, Bernardini R, Colotti B, Ilari A Cancers (Basel). 2024; 16(16).
PMID: 39199583 PMC: 11352664. DOI: 10.3390/cancers16162810.
Sorcin promotes migration in cancer and regulates the EGF-dependent EGFR signaling pathways.
Tito C, Genovese I, Giamogante F, Benedetti A, Miglietta S, Barazzuol L Cell Mol Life Sci. 2023; 80(8):202.
PMID: 37442828 PMC: 10345051. DOI: 10.1007/s00018-023-04850-4.
Goncalves C, Sesterheim P, Wartchow K, Bobermin L, Leipnitz G, Quincozes-Santos A Front Cell Neurosci. 2022; 16:905218.
PMID: 35966209 PMC: 9374064. DOI: 10.3389/fncel.2022.905218.
Zhang J, Chen J, Shan B, Lin L, Dong J, Sun Q Front Med (Lausanne). 2021; 8:752619.
PMID: 34869449 PMC: 8635117. DOI: 10.3389/fmed.2021.752619.
Ling F, Zhang H, Sun Y, Meng J, Sanches J, Huang H Cell Death Dis. 2021; 12(11):1018.
PMID: 34716295 PMC: 8556303. DOI: 10.1038/s41419-021-04287-2.